Studies
The CTN+ supports clinical trials to find new ways to prevent, treat and manage HIV and other STBBIs, prioritizing a community-based approach of the highest scientific and ethical standards.
-
CTN 330: Predicting and evaluating anal cancer in HIV with novel biomarkers (The PEACH Study)
Development and validation of an anal cancer screening algorithm in HIV-positive men who have sex with men
-
CTN 313: The DaDHS Trial
A randomized, placebo-controlled trial of oral doxycycline for the prevention of syphilis in HIV-positive men who have sex with men (MSM)
-
CTN 328: COVID-19 Vaccine in HIV
Immunogenicity outcomes in people living with HIV following vaccination for COVID-19 (HIV-COV)
-
CTN 327: Impact of COVID-19 on persons with HIV in Canada
The impact of COVID-19 on persons with HIV in Canada: Data from the HIV/HCV co-infection/CCC (CTN 222) and HIV aging cohorts (CTN 314)
-
CTN 324: Assessing the efficacy of an HPV vaccine in preventing anal pre-cancers in men living with HIV
A multicenter, randomized controlled trial of the efficacy, safety and immunogenicity of the 9-valent human papillomavirus (HPV) vaccination in preventing recurrence of high-grade anal dysplasia in HIV-positive men who have sex with men (MSM)
-
CTNPT 014: Kaletra®/Celsentri® combination therapy for HIV in the setting of HCV
An observational study of Kaletra®/Celsentri® combination therapy
-
CTN 262: Canadian HIV women’s sexual and reproductive health cohort study (CHIWOS)
Canadian HIV women’s sexual and reproductive health cohort study
-
CTN 254: Inflammation as a predictor of HIV disease progression
Predictive value of inflammatory biomarkers in untreated HIV disease progression, and their response to initiation of antiretroviral therapy
-
CTN 248: Incentives to Stop AIDS and HIV in Drug Users
A randomized clinical trial evaluating the role of contingent reinforcement in the engagement and retention of Drug Users in HAART programs: a substudy of CTN 244
-
CTN 247: Canadian cohort of HIV+ slow progressors
A study of host and viral factors associated with disease progression in long term HIV infected subjects
-
CTN 236: HPV vaccine in HIV positive girls and women
A study of an HPV VLP vaccine in a cohort of HIV positive girls and women
-
CTN 281: EPIC 4 Study
Effectiveness of early treatment with anti-retroviral therapy in children with HIV
Careers
Interested in joining our team? Here are the current career opportunities with the CTN+ and our collaborators. For Fellowship opportunities, please visit our Postdoctoral Fellowship program page.
Learn More